C
KDNY

Covestor’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Covestor’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6
Closed – – 2901
2023
Q2 		$0 Sell
6
-11
-65% -$282 ﹤0.01% 2825
2023
Q1 		$0 Buy
17
+11
+183% +$262 ﹤0.01% 2761
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2780
2022
Q3 		$0 Buy
+6
New +$120 ﹤0.01% 2803

Covestor's KDNY Position: Q3 2023 in Review

Covestor sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 6 shares.

Covestor first reported a position in KDNY in Q3 2022 and held it in 4 quarters. The position peaked at $0 in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Covestor reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Covestor sold 6 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023.
  • Covestor first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Covestor's Chinook Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Covestor's 13F filing for Q3 2023, filed 13 Nov 2023.